Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sightby making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.

$1.2B

Market Cap • 12/26/2024

2006

(18 years)
Founded

2007

(17 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Nashville

Headquarters • Tennessee